标题
New developments in biomarkers for melanoma
作者
关键词
-
出版物
CURRENT OPINION IN ONCOLOGY
Volume 25, Issue 2, Pages 145-151
出版商
Ovid Technologies (Wolters Kluwer Health)
发表日期
2013-01-18
DOI
10.1097/cco.0b013e32835dafdf
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Differential expression of microRNAs during melanoma progression: miR-200c, miR-205 and miR-211 are downregulated in melanoma and act as tumour suppressors
- (2012) Y Xu et al. BRITISH JOURNAL OF CANCER
- Immunotype and Immunohistologic Characteristics of Tumor-Infiltrating Immune Cells Are Associated with Clinical Outcome in Metastatic Melanoma
- (2012) G. Erdag et al. CANCER RESEARCH
- Loss of 5-Hydroxymethylcytosine Is an Epigenetic Hallmark of Melanoma
- (2012) Christine Guo Lian et al. CELL
- A Landscape of Driver Mutations in Melanoma
- (2012) Eran Hodis et al. CELL
- The BRAFV600E causes widespread alterations in gene methylation in the genome of melanoma cells
- (2012) Peng Hou et al. CELL CYCLE
- The Prognostic Value of FoxP3+ Tumor-Infiltrating Lymphocytes in Cancer: A Critical Review of the Literature
- (2012) R. J. deLeeuw et al. CLINICAL CANCER RESEARCH
- BRAFV600Eremodels the melanocyte transcriptome and inducesBANCRto regulate melanoma cell migration
- (2012) Ross J. Flockhart et al. GENOME RESEARCH
- Tumor-Infiltrating Lymphocyte Grade Is an Independent Predictor of Sentinel Lymph Node Status and Survival in Patients With Cutaneous Melanoma
- (2012) Farhad Azimi et al. JOURNAL OF CLINICAL ONCOLOGY
- Functional T Cells Targeting NY-ESO-1 or Melan-A Are Predictive for Survival of Patients With Distant Melanoma Metastasis
- (2012) Benjamin Weide et al. JOURNAL OF CLINICAL ONCOLOGY
- Whole genome methylation profiles as independent markers of survival in stage IIIC melanoma patients
- (2012) Luca Sigalotti et al. Journal of Translational Medicine
- Cancer classification using the Immunoscore: a worldwide task force
- (2012) Jérôme Galon et al. Journal of Translational Medicine
- Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial
- (2012) Axel Hauschild et al. LANCET
- Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma
- (2012) Michael Krauthammer et al. NATURE GENETICS
- Improved Survival with MEK Inhibition in BRAF-Mutated Melanoma
- (2012) Keith T. Flaherty et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Multi-Factorial Genetic Model for Prognostic Assessment of High Risk Melanoma Patients Receiving Adjuvant Interferon
- (2012) Ena Wang et al. PLoS One
- NRAS mutation status is an independent prognostic factor in metastatic melanoma
- (2011) John A. Jakob et al. CANCER
- Tumor-infiltrating lymphocytes: apparently good for melanoma patients. But why?
- (2011) Arcadi Cipponi et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- MicroRNA signatures differentiate melanoma subtypes
- (2011) Elcie Chan et al. CELL CYCLE
- Large-Scale Analysis of KIT Aberrations in Chinese Patients with Melanoma
- (2011) Y. Kong et al. CLINICAL CANCER RESEARCH
- Indoleamine 2,3-dioxygenase, a new prognostic marker in sentinel lymph nodes of melanoma patients
- (2011) Reinhart Speeckaert et al. EUROPEAN JOURNAL OF CANCER
- KIT as a Therapeutic Target in Metastatic Melanoma
- (2011) Richard D. Carvajal JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Prognostic and Clinicopathologic Associations of OncogenicBRAFin Metastatic Melanoma
- (2011) Georgina V. Long et al. JOURNAL OF CLINICAL ONCOLOGY
- Methylation levels of the "long interspersed nucleotide element-1" repetitive sequences predict survival of melanoma patients
- (2011) Luca Sigalotti et al. Journal of Translational Medicine
- A prospective phase II trial exploring the association between tumor microenvironment biomarkers and clinical activity of ipilimumab in advanced melanoma
- (2011) Omid Hamid et al. Journal of Translational Medicine
- MicroRNA regulation of melanoma progression
- (2011) Vanessa F. Bonazzi et al. MELANOMA RESEARCH
- EZH2-Dependent Suppression of a Cellular Senescence Phenotype in Melanoma Cells by Inhibition of p21/CDKN1A Expression
- (2011) T. Fan et al. MOLECULAR CANCER RESEARCH
- Exome sequencing identifies GRIN2A as frequently mutated in melanoma
- (2011) Xiaomu Wei et al. NATURE GENETICS
- Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
- (2011) Paul B. Chapman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma
- (2011) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- A novel oncogenic role for the miRNA-506-514 cluster in initiating melanocyte transformation and promoting melanoma growth
- (2011) K L Streicher et al. ONCOGENE
- Integrated NY-ESO-1 antibody and CD8+ T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab
- (2011) J. Yuan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Molecular Profiling of Melanoma and the Evolution of Patient-Specific Therapy
- (2011) Thomas F. Gajewski SEMINARS IN ONCOLOGY
- SWI/SNF chromatin remodeling complex is critical for the expression of microphthalmia-associated transcription factor in melanoma cells
- (2010) Jiri Vachtenheim et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Genome-wide methylation and expression profiling identifies promoter characteristics affecting demethylation-induced gene up-regulation in melanoma
- (2010) Jill C Rubinstein et al. BMC Medical Genomics
- Single-institution experience with ipilimumab in advanced melanoma patients in the compassionate use setting
- (2010) Geoffrey Y. Ku et al. CANCER
- Signatures of MicroRNAs and Selected MicroRNA Target Genes in Human Melanoma
- (2010) D. Philippidou et al. CANCER RESEARCH
- A Temporarily Distinct Subpopulation of Slow-Cycling Melanoma Cells Is Required for Continuous Tumor Growth
- (2010) Alexander Roesch et al. CELL
- Extended Dose Ipilimumab with a Peptide Vaccine: Immune Correlates Associated with Clinical Benefit in Patients with Resected High-Risk Stage IIIc/IV Melanoma
- (2010) A. A. Sarnaik et al. CLINICAL CANCER RESEARCH
- SWItching on the transcriptional circuitry in melanoma
- (2010) Srinivas Vinod Saladi et al. Epigenetics
- A new era: melanoma genetics and therapeutics
- (2010) Justin M Ko et al. JOURNAL OF PATHOLOGY
- Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma
- (2010) Gideon Bollag et al. NATURE
- Mammalian microRNAs predominantly act to decrease target mRNA levels
- (2010) Huili Guo et al. NATURE
- Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
- (2010) Keith T. Flaherty et al. NEW ENGLAND JOURNAL OF MEDICINE
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mutations in KIT occur at low frequency in melanomas arising from anatomical sites associated with chronic and intermittent sun exposure
- (2010) Despina Handolias et al. Pigment Cell & Melanoma Research
- Characterization of the Melanoma miRNAome by Deep Sequencing
- (2010) Mitchell S. Stark et al. PLoS One
- CpG Island Methylator Phenotype Predicts Progression of Malignant Melanoma
- (2009) A. Tanemura et al. CLINICAL CANCER RESEARCH
- Results of a Phase III, Randomized, Placebo-Controlled Study of Sorafenib in Combination With Carboplatin and Paclitaxel As Second-Line Treatment in Patients With Unresectable Stage III or Stage IV Melanoma
- (2009) Axel Hauschild et al. JOURNAL OF CLINICAL ONCOLOGY
- Final Version of 2009 AJCC Melanoma Staging and Classification
- (2009) Charles M. Balch et al. JOURNAL OF CLINICAL ONCOLOGY
- Methylation of PTEN as a Prognostic Factor in Malignant Melanoma of the Skin
- (2009) Christoph Lahtz et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Loss of BMI-1 expression is associated with clinical progress of malignant melanoma
- (2008) Ingeborg M Bachmann et al. MODERN PATHOLOGY
- Integrin β3 expression is regulated by let-7a miRNA in malignant melanoma
- (2008) D W Müller et al. ONCOGENE
- Identification of novel epigenetically modified genes in human melanoma via promoter methylation gene profiling
- (2008) Suhu Liu et al. Pigment Cell & Melanoma Research
- MicroRNA-373 induces expression of genes with complementary promoter sequences
- (2008) R. F. Place et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now